Informationen:
Fehler:
ID
31499
Beschreibung
Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD; ODM derived from: https://clinicaltrials.gov/show/NCT00428948
Link
https://clinicaltrials.gov/show/NCT00428948
Stichworte
Versionen (1)
- 28.08.18 28.08.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
28. August 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948
Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Estimated Glomerular Filtration Rate
Item
gfr estimated at ≥60 ml/ min
boolean
C3811844 (UMLS CUI [1])
Autosomal Dominant Polycystic Kidney Disease | Kidney Growth Rapidly progressive MRI | Kidney Total Volume MRI
Item
diagnosis of adpkd and rapidly progressive kidney growth (total volume ≥750 cc) by magnetic resonance imaging (mri) at randomization
boolean
C0085413 (UMLS CUI [1])
C0022646 (UMLS CUI [2,1])
C0018270 (UMLS CUI [2,2])
C1838681 (UMLS CUI [2,3])
C0024485 (UMLS CUI [2,4])
C0022646 (UMLS CUI [3,1])
C0449468 (UMLS CUI [3,2])
C0024485 (UMLS CUI [3,3])
C0022646 (UMLS CUI [2,1])
C0018270 (UMLS CUI [2,2])
C1838681 (UMLS CUI [2,3])
C0024485 (UMLS CUI [2,4])
C0022646 (UMLS CUI [3,1])
C0449468 (UMLS CUI [3,2])
C0024485 (UMLS CUI [3,3])
Legal Adult | Informed Consent
Item
legal adult age and able to give informed consent
boolean
C1706450 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])
Gender | Contraceptive methods Willing
Item
willingness to comply with reproductive precautions if female
boolean
C0079399 (UMLS CUI [1])
C0700589 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Exposure to Tolvaptan | Exposure to Experimental Therapies Polycystic Kidney Diseases
Item
prior exposure to tolvaptan or other experimental pkd therapies
boolean
C0332157 (UMLS CUI [1,1])
C1176308 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0949266 (UMLS CUI [2,2])
C0022680 (UMLS CUI [2,3])
C1176308 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0949266 (UMLS CUI [2,2])
C0022680 (UMLS CUI [2,3])
Pharmaceutical Preparations Affecting PKD Cysts
Item
currently taking medication for purpose of affecting pkd cysts
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0022680 (UMLS CUI [1,3])
C0010709 (UMLS CUI [1,4])
C0392760 (UMLS CUI [1,2])
C0022680 (UMLS CUI [1,3])
C0010709 (UMLS CUI [1,4])
Breast Feeding | Childbearing Potential Contraceptive methods Absent
Item
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
boolean
C0006147 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Safety Risk | Interference Study Protocol
Item
in the opinion of the study investigator or sponsor may present a safety risk or confound study objectives
boolean
C0036043 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0521102 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0035647 (UMLS CUI [1,2])
C0521102 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Protocol Compliance Unlikely
Item
patients who are unlikely to adequately comply with study procedures
boolean
C0525058 (UMLS CUI [1,1])
C0750558 (UMLS CUI [1,2])
C0750558 (UMLS CUI [1,2])
Medical contraindication MRI
Item
patients having contraindications to mri
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,2])
Pharmaceutical Preparations Affecting Autosomal Dominant Polycystic Kidney Disease Outcome | Illness Affecting Autosomal Dominant Polycystic Kidney Disease Outcome
Item
patients taking medications or having any illnesses likely to affect adpkd outcomes.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0085413 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,4])
C0221423 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0085413 (UMLS CUI [2,3])
C1274040 (UMLS CUI [2,4])
C0392760 (UMLS CUI [1,2])
C0085413 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,4])
C0221423 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0085413 (UMLS CUI [2,3])
C1274040 (UMLS CUI [2,4])